TXP Medical develops medical data systems for emergency and intensive care, cancer treatment support, medical AI, and consulting.
TXP Medical has raised $16.1M in total funding. The most recent round was Series C. The last funding was announced in October 2024.
TXP Medical's investors include UTEC - The University of Tokyo Edge Capital Partners, NTT Communications, MPower Partners, Medical Data Vision.
TXP Medical is headquartered in Tokyo, Japan.
TXP Medical develops medical data systems for emergency and intensive care, cancer treatment support, medical AI, and consulting.
TXP Medical is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TXP Medical — Funding & Investors." VCBacked, October 23, 2024, https://www.vcbacked.co/company/txp-medical. Accessed August 14, 2026.
VCBacked. (2024). TXP Medical — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/txp-medical
{{cite web |title=TXP Medical — Funding & Investors |url=https://www.vcbacked.co/company/txp-medical |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated